US Patent 11136381 Anti-C3 antibodies
Patent 11136381 was granted and assigned to NGM Biopharmaceuticals on October, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 1, 2019
Date of Patent
October 5, 2021
Patent Applicant
Patent Application Number
20190401
Patent Citations Received
Patent Jurisdiction
Patent Number
Find more entities like US Patent 11136381 Anti-C3 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.